These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 132525)

  • 1. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
    Trulson ME; Eubanks EE; Jacobs BL
    J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME; Ross CA; Jacobs BL
    Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of a rat behavioral model for serotonin receptor activation.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):339-47. PubMed ID: 682117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine.
    Trulson ME; Jacobs BL
    Eur J Pharmacol; 1976 Mar; 36(1):149-54. PubMed ID: 131036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals.
    Trulson ME; Jacobs BL
    Ann N Y Acad Sci; 1978 Jun; 305():497-509. PubMed ID: 309301
    [No Abstract]   [Full Text] [Related]  

  • 6. Exposure to high pressure may produce the 5-HT behavioral syndrome in rats.
    Wardley-Smith B; Hudson S; Doré CJ; Charlett A; Fletcher A; Brammer NT; Minchin MC; Wann KT
    Undersea Biomed Res; 1990 Jul; 17(4):275-86. PubMed ID: 1697708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-OHDA), 5,6-dihydroxytryptamine (5,6-DHT) or repeated monoamine administration.
    Howe JR; Yaksh TL
    J Pharmacol Exp Ther; 1982 Feb; 220(2):311-21. PubMed ID: 6120226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central serotonin receptor sensitivity in rats with experimental allergic encephalomyelitis.
    White SR; Bieger D
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):269-81. PubMed ID: 6969416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that serotonin mediates some behavioral effects of amphetamine.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and biochemical effects of para-methoxyphenylethylamine.
    Hwang EC; Van Woert MH
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):419-31. PubMed ID: 461968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence from behavioural reactions to fenfluramine, 5-hydroxytryptophan, and 5-methoxy-N,N-dimethyltryptamine for differential effects of short-term and long-term lithium on indoleaminergic mechanisms in rats [proceedings].
    Harrison-Read PE
    Br J Pharmacol; 1979 May; 66(1):144P-145P. PubMed ID: 313227
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats.
    Batool F; Haleem DJ
    Pak J Pharm Sci; 2008 Oct; 21(4):411-20. PubMed ID: 18930864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased behavioural response to intrathecal serotonin after lesion of serotonergic pathways with 5,7-dihydroxytryptamine seems not to be due to depletion of serotonin.
    Eide PK; Hole K
    Acta Physiol Scand; 1988 Oct; 134(2):291-4. PubMed ID: 2976239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
    Pranzatelli MR; Huang YY; Dollison AM; Stanley M
    Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a role of brain serotonergic neurotransmission in avoidance learning.
    Ogren SO
    Acta Physiol Scand Suppl; 1985; 544():1-71. PubMed ID: 3006431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal cord injury-specific depression of monosynaptic spinal reflex transmission by l-5-hydroxytryptophan results from loss of the 5-HT uptake system and not 5-HT receptor supersensitivity.
    Honda M; Tanabe M; Ono H
    Exp Neurol; 2006 Nov; 202(1):258-61. PubMed ID: 16806182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.
    Boban Blagaic A; Blagaic V; Mirt M; Jelovac N; Dodig G; Rucman R; Petek M; Turkovic B; Anic T; Dubovecak M; Staresinic M; Seiwerth S; Sikiric P
    Eur J Pharmacol; 2005 Apr; 512(2-3):173-9. PubMed ID: 15840402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.